在心力衰竭中心房动的流行病学
Nikhila Chelikam1, Aashish Katapadi1, Naga Venkata Pothineni1
1Department of Electrophysiology, Kansas City Heart Rhythm Institute, Overland Park, KS 66211, USA.
Cardiac electrophysiology clinics
|February 1, 2025
概括
心房动和心力衰竭是常见的心血管疾病,通过复杂的机制相互恶化. 了解它们的相互作用对于改善患者护理和结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 病理生理学 病理生理学
- 流行病学 流行病学
背景情况:
- 心房动和心力衰竭是常见的心血管疾病.
- 这些条件共享一个复杂的病理生理关系,影响发病率和死亡率.
- 人口老龄化正在增加这些交织在一起的疾病的负担.
研究的目的:
- 探索心房动和心力衰竭之间的复杂关系.
- 了解将这两种情况联系在一起的病理生理机制.
- 突出流行病学见解对患者护理的重要性.
主要方法:
- 关于心房动和心力衰竭的现有文献的综述.
- 对连接这两种情况的病理生理环境的分析.
- 讨论流行病学趋势及其影响.
主要成果:
- 在心房动和心力衰竭之间存在一个恶性循环,涉及神经激素变化,炎症和心肌重塑.
- 心肌病可以导致心房动,心房动可以导致心力衰竭,往往使因果关系难以确定.
- 这种双向关系加剧了疾病的进展和患者的结果.
结论:
- 心房动和心力衰竭之间的相互作用在心血管医学中是一个重大挑战.
- 进一步研究流行病学和病理生理学对于开发有效的治疗策略至关重要.
- 改善理解对于管理这些常见且具有影响力的心血管疾病至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Disturbances in Heart Rhythm
884
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Heart Failure Drugs: β-Blockers
311
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Increased pulse rate
636
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
636


